Environmental monitoring is a critical part of the sterility assurance of drug products. It is a highly regulated field, especially in viable air monitoring.


Regulations create a dilemma for the manufacturer as they require frequent/continuous monitoring to take place as close as possible to critical control points without adding any risk to the final product or the test itself. 1


Current sampling methods do not have the capability to fulfill all regulatory requirements. They either provide a snapshot of the manufacturing process, or impose a risk to the process through frequent handling interference when performed close to sampling points identified by risk assessment.


The concept of continuous monitoring, now a worldwide-accepted standard for non-viable particle testing, should be transferred to viable air monitoring to improve monitoring effectiveness while removing most handling interference.

Industry-Leading Viable Air Monitoring
In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.